Latest News & Features
Refine Search
Americas
Biotechnology company Capricor Therapeutics has agreed to acquire patents from medical equipment maker Medtronic as part of plans to develop a programme to treat heart failure. 15 October 2014
Americas
The highest court in the US will hear a dispute today (October 15) between pharmaceutical company Teva and generic rivals that are looking to market versions of its multiple sclerosis drug Copaxone (glatiramer acetate). 15 October 2014
Big Pharma
UK-based law firm Carpmaels & Ransford LLP has continued to expand its IP group with the appointment of a life sciences litigator to its London office. 15 October 2014
Americas
The US government has launched a new investigation into India’s IP regime just weeks after a meeting between the country’s new prime minister and US President Barack Obama. 14 October 2014
Asia
US pharmaceutical company Pfizer has been granted a patent for an anti-fungal drug in India after overcoming local opposition. 13 October 2014
Americas
Law firm Arnold & Porter LLP has appointed a new a partner to its life sciences team. 10 October 2014
Americas
US biopharmaceutical company Sucampo has resolved patent litigation related to, and agreed a licensing deal for, its Amitiza (lubiprostone) capsules, used to treat constipation. 10 October 2014
Asia-Pacific
Criminal gangs in Australia are branching away from traditional forms of counterfeiting and are targeting pharmaceuticals, an Australian customs official has revealed. 9 October 2014
Genetics
A US appeals court has heard oral arguments in a case between Myriad Genetics and a generics company it wants to prevent from marketing its own test for BRCA gene mutations that can lead to breast cancer. 8 October 2014
Biotechnology
A patent belonging to Pluristem Therapeutics covering a treatment for ischemia has been upheld by the European Patent Office following opposition proceedings, the company has announced. 8 October 2014